Bill Texts: US HB3839 | 2023-2024 | 118th Congress

Bill Title: To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.

Spectrum: Bipartisan Bill

Status: (Introduced - Dead) 2023-06-09 - Referred to the Subcommittee on Health. [HB3839 Detail]

Bill Drafts

RevisionDateFormatSourceView
Introduced2023-07-03PDFLinkView

Amendments

AmendmentDateDispositionFormatSourceView
No bill amendments currently on file for US Congress HB3839

Supplemental Documents

TitleDescriptionDateFormatSourceView
No supplemental documents for US Congress HB3839 currently on file.

Social Comments on US HB3839

feedback